These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27464697)

  • 21. Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children.
    Kim YI; Murphy R; Majumdar S; Harrison LG; Aitken J; DeVincenzo JP
    Pediatr Res; 2015 Oct; 78(4):380-8. PubMed ID: 26107392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in viral load among human respiratory syncytial virus genotypes in hospitalized children with severe acute respiratory infections in the Philippines.
    Kadji FM; Okamoto M; Furuse Y; Tamaki R; Suzuki A; Lirio I; Dapat C; Malasao R; Saito M; Pedrera-Rico GA; Tallo V; Lupisan S; Saito M; Oshitani H
    Virol J; 2016 Jun; 13():113. PubMed ID: 27350282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Respiratory Syncytial Virus: An Introduction.
    Jorquera PA; Anderson L; Tripp RA
    Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a lethal aged mouse model of human respiratory syncytial virus infection.
    Zhang K; Li C; Luo YS; Wen L; Yuan S; Wang D; Ho-Yin Wong B; Zhao X; Chiu MC; Ye ZW; Sun Z; Zhao H; Zhang X; Hu M; Yang D; Shuai H; Wang Y; He J; Bose ME; Henrickson KJ; Huang JD; Zheng B; Chu H; Zhou J
    Antiviral Res; 2019 Jan; 161():125-133. PubMed ID: 30503888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system alterations caused by infection with the human respiratory syncytial virus.
    Bohmwald K; Espinoza JA; González PA; Bueno SM; Riedel CA; Kalergis AM
    Rev Med Virol; 2014 Nov; 24(6):407-19. PubMed ID: 25316031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
    Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
    Dunn MC; Knight DA; Waldman WJ
    Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors.
    Grandin C; Hourani ML; Janin YL; Dauzonne D; Munier-Lehmann H; Paturet A; Taborik F; Vabret A; Contamin H; Tangy F; Vidalain PO
    Antiviral Res; 2016 Jan; 125():58-62. PubMed ID: 26593978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.
    Broadbent L; Groves H; Shields MD; Power UF
    Influenza Other Respir Viruses; 2015 Jul; 9(4):169-78. PubMed ID: 25847510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus infected infants.
    Brint ME; Hughes JM; Shah A; Miller CR; Harrison LG; Meals EA; Blanch J; Thompson CR; Cormier SA; DeVincenzo JP
    Pediatr Res; 2017 Nov; 82(5):872-880. PubMed ID: 28723886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
    Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission.
    Oomens AG; Wertz GW
    J Virol; 2004 Sep; 78(17):9064-72. PubMed ID: 15308702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection.
    Rajagopala SV; Singh H; Patel MC; Wang W; Tan Y; Shilts MH; Hartert TV; Boukhvalova MS; Blanco JCG; Das SR
    Sci Rep; 2018 Jul; 8(1):11318. PubMed ID: 30054492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts.
    Stittelaar KJ; de Waal L; van Amerongen G; Veldhuis Kroeze EJ; Fraaij PL; van Baalen CA; van Kampen JJ; van der Vries E; Osterhaus AD; de Swart RL
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27314379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection.
    Espinoza JA; León MA; Céspedes PF; Gómez RS; Canedo-Marroquín G; Riquelme SA; Salazar-Echegarai FJ; Blancou P; Simon T; Anegon I; Lay MK; González PA; Riedel CA; Bueno SM; Kalergis AM
    J Immunol; 2017 Jul; 199(1):212-223. PubMed ID: 28566367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of the PER.C6 cell line for infection with clinical human respiratory syncytial virus isolates.
    Houspie L; Keyaerts E; Maes P; Van Ranst M
    J Virol Methods; 2012 Apr; 181(1):37-42. PubMed ID: 22305961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.